{
  "Aspirin": {
    "success": true,
    "compound_id": "Aspirin",
    "smiles": "CC(=O)Oc1ccccc1C(=O)O",
    "prediction_engine": "RDKit + Trained ML Models",
    "molecular_weight": 180.159,
    "logp": 1.31,
    "tpsa": 63.6,
    "num_hbd": 1,
    "num_hba": 3,
    "num_rotatable_bonds": 2,
    "num_aromatic_rings": 1,
    "num_heavy_atoms": 13,
    "num_aliphatic_rings": 0,
    "num_saturated_rings": 0,
    "fraction_csp3": 0.111,
    "molar_refractivity": 44.71,
    "qed_score": 0.55,
    "synthetic_accessibility": 1,
    "lipinski_pass": true,
    "lipinski_violations": 0,
    "lipinski_details": "Pass (0 violations)",
    "veber_pass": true,
    "veber_details": "Pass",
    "ghose_pass": false,
    "ghose_details": "Fail (Heavy atoms: 13 (range: 20-70))",
    "egan_pass": true,
    "egan_details": "Pass",
    "muegge_pass": false,
    "muegge_details": "Fail (MW: 180.159 (range: 200-600); Aromatic rings: 1 (range: 2-7))",
    "pains_alert": false,
    "brenk_alert": true,
    "prediction_warnings": "Brenk alerts: 1",
    "caco2_permeability_category": "Medium",
    "human_intestinal_absorption_category": "Good",
    "bbb_permeability_category": "High",
    "cns_permeability_category": "High",
    "overall_drug_likeness": "Good",
    "overall_safety_profile": "Concerning",
    "ml_model_version": "1.0.0",
    "ml_model_name": "sklearn_ensemble",
    "ml_model_auc": 0.7101480926110298,
    "tox21_nr_ar": 0.020677511172157423,
    "tox21_nr_ar_label": "Inactive",
    "tox21_nr_ar_lbd": 0.0017389838872672054,
    "tox21_nr_ar_lbd_label": "Inactive",
    "tox21_nr_ahr": 0.02087203691381793,
    "tox21_nr_ahr_label": "Inactive",
    "tox21_nr_aromatase": 0.002318227277582358,
    "tox21_nr_aromatase_label": "Inactive",
    "tox21_nr_er": 0.06374440928001521,
    "tox21_nr_er_label": "Inactive",
    "tox21_nr_er_lbd": 0.004441708526482753,
    "tox21_nr_er_lbd_label": "Inactive",
    "tox21_nr_ppar_gamma": 0.003262479796709618,
    "tox21_nr_ppar_gamma_label": "Inactive",
    "tox21_sr_are": 0.03263674154292353,
    "tox21_sr_are_label": "Inactive",
    "tox21_sr_atad5": 0.0027892636035025896,
    "tox21_sr_atad5_label": "Inactive",
    "tox21_sr_hse": 0.007541920919293125,
    "tox21_sr_hse_label": "Inactive",
    "tox21_sr_mmp": 0.025975138089275276,
    "tox21_sr_mmp_label": "Inactive",
    "tox21_sr_p53": 0.004638166213656639,
    "tox21_sr_p53_label": "Inactive",
    "clintox_fda_approved": 0.25288262839697195,
    "clintox_ct_tox": 0.7420360848797429,
    "hepatotoxicity_ml": 0.017476912511276598,
    "hepatotoxicity_level": "Low",
    "cardiotoxicity_ml": 0.029305939816099403,
    "cardiotoxicity_level": "Low",
    "nephrotoxicity_ml": 0.022972456329147507,
    "nephrotoxicity_level": "Low",
    "neurotoxicity_ml": 0.019246977303964425,
    "neurotoxicity_level": "Low",
    "ensemble_std": {
      "tox21_NR-AR": 0.005322488827842577,
      "tox21_NR-AR-LBD": 0.00026101611273279454,
      "tox21_NR-AhR": 0.006872036913817932,
      "tox21_NR-Aromatase": 0.002318227277582358,
      "tox21_NR-ER": 0.011853255109838288,
      "tox21_NR-ER-LBD": 0.002441708526482753,
      "tox21_NR-PPAR-gamma": 0.001262479796709618,
      "tox21_SR-ARE": 0.01863674154292353,
      "tox21_SR-ATAD5": 0.0027892636035025896,
      "tox21_SR-HSE": 0.0035419209192931247,
      "tox21_SR-MMP": 0.003975138089275276,
      "tox21_SR-p53": 0.0006381662136566392,
      "clintox_FDA_APPROVED": 0.14111737160302806,
      "clintox_CT_TOX": 0.1320360848797429
    },
    "hepatotoxicity_factors": "Low TPSA (64)",
    "hepatotoxicity_confidence": 0.75,
    "cardiotoxicity_factors": null,
    "cardiotoxicity_confidence": 0.7,
    "mutagenicity_ml": 0.3,
    "mutagenicity_level": "Low",
    "mutagenicity_factors": "Brenk alerts (1)",
    "mutagenicity_confidence": 0.8,
    "clinical_toxicity_ml": 0.1,
    "clinical_toxicity_level": "Low",
    "clinical_toxicity_confidence": 0.65,
    "carcinogenicity_ml": 0.2,
    "carcinogenicity_level": "Low",
    "carcinogenicity_factors": "Toxic structural alerts",
    "carcinogenicity_confidence": 0.6,
    "nephrotoxicity_factors": null,
    "nephrotoxicity_confidence": 0.55,
    "neurotoxicity_factors": "High BBB penetration potential",
    "neurotoxicity_confidence": 0.5,
    "ad_in_domain": true,
    "ad_status": "BORDERLINE",
    "ad_reliability_score": 0.4,
    "ad_tanimoto_score": 1.0,
    "ad_distance_score": 0.0,
    "ad_leverage_score": 0.0,
    "ad_warnings": null,
    "prediction_ci_lower": {
      "hepatotoxicity_ml": 0.0034953825022553276,
      "cardiotoxicity_ml": 0.005861187963219872,
      "nephrotoxicity_ml": 0.004594491265829493,
      "neurotoxicity_ml": 0.003849395460792899,
      "hepatotoxicity_confidence": 0.55,
      "cardiotoxicity_confidence": 0.4599999999999999,
      "mutagenicity_ml": 0.06,
      "mutagenicity_confidence": 0.6400000000000001,
      "carcinogenicity_ml": 0.03999999999999998,
      "carcinogenicity_confidence": 0.2799999999999999,
      "nephrotoxicity_confidence": 0.19000000000000006,
      "neurotoxicity_confidence": 0.09999999999999998
    },
    "prediction_ci_upper": {
      "hepatotoxicity_ml": 0.03145844252029787,
      "cardiotoxicity_ml": 0.05275069166897893,
      "nephrotoxicity_ml": 0.04135042139246552,
      "neurotoxicity_ml": 0.03464455914713595,
      "hepatotoxicity_confidence": 0.95,
      "cardiotoxicity_confidence": 0.94,
      "mutagenicity_ml": 0.54,
      "mutagenicity_confidence": 0.96,
      "carcinogenicity_ml": 0.36000000000000004,
      "carcinogenicity_confidence": 0.92,
      "nephrotoxicity_confidence": 0.91,
      "neurotoxicity_confidence": 0.9
    },
    "prediction_intervals": {
      "hepatotoxicity_ml": 0.027963060018042545,
      "cardiotoxicity_ml": 0.04688950370575906,
      "nephrotoxicity_ml": 0.03675593012663603,
      "neurotoxicity_ml": 0.03079516368634305,
      "hepatotoxicity_confidence": 0.3999999999999999,
      "cardiotoxicity_confidence": 0.48000000000000004,
      "mutagenicity_ml": 0.48000000000000004,
      "mutagenicity_confidence": 0.31999999999999984,
      "carcinogenicity_ml": 0.32000000000000006,
      "carcinogenicity_confidence": 0.6400000000000001,
      "nephrotoxicity_confidence": 0.72,
      "neurotoxicity_confidence": 0.8
    },
    "confidence_level": 0.9,
    "uncertainty_method": "split_conformal",
    "pri_score": 0.5606,
    "pri_category": "moderate",
    "pri_ad_component": 0.4,
    "pri_ensemble_component": 0.8959,
    "pri_conformal_component": 0.5578,
    "pri_performance_component": 0.4203,
    "pri_per_endpoint": {
      "tox21_nr_ar": 0.5724,
      "tox21_nr_ar_lbd": 0.5749,
      "tox21_nr_ahr": 0.5716,
      "tox21_nr_aromatase": 0.5739,
      "tox21_nr_er": 0.5691,
      "tox21_nr_er_lbd": 0.5739,
      "tox21_nr_ppar_gamma": 0.5744,
      "tox21_sr_are": 0.5658,
      "tox21_sr_atad5": 0.5737,
      "tox21_sr_hse": 0.5733,
      "tox21_sr_mmp": 0.5731,
      "tox21_sr_p53": 0.5748,
      "clintox_fda_approved": 0.5045,
      "clintox_ct_tox": 0.5091,
      "hepatotoxicity_ml": 0.5445,
      "cardiotoxicity_ml": 0.5407
    },
    "pri_per_endpoint_category": {
      "tox21_nr_ar": "moderate",
      "tox21_nr_ar_lbd": "moderate",
      "tox21_nr_ahr": "moderate",
      "tox21_nr_aromatase": "moderate",
      "tox21_nr_er": "moderate",
      "tox21_nr_er_lbd": "moderate",
      "tox21_nr_ppar_gamma": "moderate",
      "tox21_sr_are": "moderate",
      "tox21_sr_atad5": "moderate",
      "tox21_sr_hse": "moderate",
      "tox21_sr_mmp": "moderate",
      "tox21_sr_p53": "moderate",
      "clintox_fda_approved": "moderate",
      "clintox_ct_tox": "moderate",
      "hepatotoxicity_ml": "moderate",
      "cardiotoxicity_ml": "moderate"
    },
    "pri_n_endpoints": 16,
    "pri_weights": {
      "ad_score": 0.3,
      "ensemble_uncertainty": 0.25,
      "conformal_width": 0.2,
      "model_performance": 0.25
    },
    "cds_score": 62.5,
    "cds_category": "good",
    "cds_traffic_light": "yellow",
    "cds_drug_likeness": 75.0,
    "cds_metabolic_stability": 60.0,
    "cds_safety_profile": 55.0,
    "cds_permeability": 50.0,
    "cds_physicochemical": 70.0,
    "cds_optimization": "Improve Permeability (score: 50/100); Improve Safety (score: 55/100);   - Address: Clinical toxicity risk (0.74)",
    "cds_regulatory_risk": "low",
    "cds_benchmark_percentile": 63.3,
    "cds_benchmark_comparison": "MW: outside typical range (180.2); Logp: in IQR (1.3, range 1.2-3.8); TPSA: in IQR (63.6, range 50-110); Rotatable Bonds: favorable (2, median=5)",
    "bcs_class": "I",
    "bcs_description": "High solubility, high permeability - favorable for oral delivery",
    "bcs_solubility_category": "high",
    "bcs_permeability_category": "high",
    "bcs_biowaiver_eligible": true,
    "bcs_development_risk": "low",
    "bcs_absorption_score": 82.2,
    "bcs_logS": -1.99,
    "bcs_solubility_mg_ml": 1.8358,
    "bcs_permeability_score": 0.88,
    "bcs_permeability_sources": "Descriptors",
    "bcs_logS_pH1.2": -1.99,
    "bcs_logS_pH4.5": -1.52,
    "bcs_logS_pH6.8": 0.61,
    "bcs_logS_pH7.4": 1.21,
    "bcs_estimated_pka": 4.2,
    "bcs_ionization_type": "acid",
    "bcs_formulation_strategies": "Conventional immediate-release tablets; Simple capsule formulations; Oral solutions or suspensions",
    "bcs_formulation_considerations": "Biowaivers eligible (FDA/EMA) - in vitro dissolution sufficient; Excipient selection is flexible; Standard direct compression or wet granulation",
    "bcs_recommended_excipients": "Fillers: Microcrystalline cellulose (MCC), Lactose monohydrate; Binders: PVP K30, HPMC E5; Disintegrants: Croscarmellose sodium, Sodium starch glycolate",
    "metabolism_n_metabolites": 5,
    "metabolism_primary_cyps": "CYP1A2, CYP2C9, CYP2D6, CYP3A4, Esterases",
    "metabolism_reactive_risk": "low",
    "metabolism_liability_score": 38.8,
    "metabolism_soft_spots": "Aromatic hydroxylation (CYP-mediated); Ester hydrolysis (carboxylesterase-mediated)",
    "metabolism_reaction_types": "oxidation: 4; hydrolysis: 1",
    "metabolism_dili_risk": "low",
    "metabolite_1_smiles": "CC(=O)Oc1c(O)cccc1C(=O)O",
    "metabolite_1_reaction": "Aromatic hydroxylation (CYP-mediated)",
    "metabolite_1_cyps": "CYP1A2, CYP2C9, CYP2D6",
    "metabolite_1_priority": 1,
    "metabolite_2_smiles": "CC(=O)Oc1cc(O)ccc1C(=O)O",
    "metabolite_2_reaction": "Aromatic hydroxylation (CYP-mediated)",
    "metabolite_2_cyps": "CYP1A2, CYP2C9, CYP2D6",
    "metabolite_2_priority": 1,
    "metabolite_3_smiles": "CC(=O)Oc1ccc(O)cc1C(=O)O",
    "metabolite_3_reaction": "Aromatic hydroxylation (CYP-mediated)",
    "metabolite_3_cyps": "CYP1A2, CYP2C9, CYP2D6",
    "metabolite_3_priority": 1,
    "metabolite_4_smiles": "CC(=O)Oc1cccc(O)c1C(=O)O",
    "metabolite_4_reaction": "Aromatic hydroxylation (CYP-mediated)",
    "metabolite_4_cyps": "CYP1A2, CYP2C9, CYP2D6",
    "metabolite_4_priority": 1,
    "metabolite_5_smiles": "O=C(O)c1ccccc1O",
    "metabolite_5_reaction": "Ester hydrolysis (carboxylesterase-mediated)",
    "metabolite_5_cyps": "Esterases, CES1, CES2",
    "metabolite_5_priority": 2,
    "cyp3a4_inhibitor": 0.15,
    "cyp2d6_inhibitor": 0.1,
    "cyp2c9_inhibitor": 0.25,
    "cyp2c19_inhibitor": 0.1,
    "cyp1a2_inhibitor": 0.25,
    "ddi_risk_score": 0.0,
    "ddi_risk_category": "low",
    "ddi_n_cyp_interactions": 0,
    "ddi_max_inhibition": "none",
    "ddi_primary_pathway": "CYP1A2 (unlikely inhibitor, P=0.25)",
    "ddi_pgp_risk": "minimal",
    "ddi_perpetrator_role": "none",
    "ddi_victim_role": "none",
    "ddi_cyp1_enzyme": "CYP1A2",
    "ddi_cyp1_prob": 0.25,
    "ddi_cyp1_strength": "unlikely",
    "ddi_cyp1_at_risk": "Theophylline, Caffeine, Tizanidine, Duloxetine",
    "ddi_cyp2_enzyme": "CYP2C9",
    "ddi_cyp2_prob": 0.25,
    "ddi_cyp2_strength": "unlikely",
    "ddi_cyp2_at_risk": "Warfarin (S), Phenytoin, Celecoxib, Losartan",
    "ddi_cyp3_enzyme": "CYP3A4",
    "ddi_cyp3_prob": 0.15,
    "ddi_cyp3_strength": "unlikely",
    "ddi_cyp3_at_risk": "Midazolam, Triazolam, Simvastatin, Lovastatin",
    "comparative_n_similar": 1,
    "comparative_drug_space_score": 100.0,
    "comparative_within_drug_space": true,
    "comparative_most_similar": "Warfarin",
    "comparative_similarity": 0.245,
    "comparative_drug_1_name": "Warfarin",
    "comparative_drug_1_class": "Anticoagulant",
    "comparative_drug_1_similarity": 0.245,
    "comparative_drug_1_bcs": "I",
    "comparative_strengths": "LogP in optimal range (1.3); Molecular weight in optimal range (180.2); TPSA in optimal range (63.6); Strong Absorption profile (score: 81/100); Better LogP than similar drugs (1.3 vs avg 2.6 in Warfarin)",
    "comparative_weaknesses": "Weak Safety profile (score: 28/100)",
    "bro5_compound_class": "ro5_compliant",
    "bro5_is_bro5": false,
    "bro5_ro5_violations": 0,
    "bro5_drug_likeness": 100.0,
    "bro5_oral_bioavailability_risk": "low",
    "bro5_recommendations": "Ro5-compliant: standard oral formulation approaches applicable",
    "aop_n_triggered": 0,
    "aop_risk_score": 0.0,
    "aop_risk_category": "low"
  },
  "Simvastatin": {
    "success": true,
    "compound_id": "Simvastatin",
    "smiles": "CCC(C)(C)C(=O)OC1CC(O)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21",
    "prediction_engine": "RDKit + Trained ML Models",
    "molecular_weight": 420.546,
    "logp": 3.31,
    "tpsa": 93.06,
    "num_hbd": 2,
    "num_hba": 6,
    "num_rotatable_bonds": 6,
    "num_aromatic_rings": 0,
    "num_heavy_atoms": 30,
    "num_aliphatic_rings": 3,
    "num_saturated_rings": 1,
    "fraction_csp3": 0.75,
    "molar_refractivity": 112.298,
    "qed_score": 0.641,
    "synthetic_accessibility": 1,
    "lipinski_pass": true,
    "lipinski_violations": 0,
    "lipinski_details": "Pass (0 violations)",
    "veber_pass": true,
    "veber_details": "Pass",
    "ghose_pass": true,
    "ghose_details": "Pass",
    "egan_pass": true,
    "egan_details": "Pass",
    "muegge_pass": false,
    "muegge_details": "Fail (Aromatic rings: 0 (range: 2-7))",
    "pains_alert": false,
    "brenk_alert": false,
    "prediction_warnings": null,
    "caco2_permeability_category": "Medium",
    "human_intestinal_absorption_category": "Good",
    "bbb_permeability_category": "Medium",
    "cns_permeability_category": "Medium",
    "overall_drug_likeness": "Excellent",
    "overall_safety_profile": "Good",
    "ml_model_version": "1.0.0",
    "ml_model_name": "sklearn_ensemble",
    "ml_model_auc": 0.7101480926110298,
    "tox21_nr_ar": 0.7030816149862604,
    "tox21_nr_ar_label": "Active",
    "tox21_nr_ar_lbd": 0.015505310097378829,
    "tox21_nr_ar_lbd_label": "Inactive",
    "tox21_nr_ahr": 0.008944111815250793,
    "tox21_nr_ahr_label": "Inactive",
    "tox21_nr_aromatase": 0.3518049317862052,
    "tox21_nr_aromatase_label": "Inactive",
    "tox21_nr_er": 0.6079103724577279,
    "tox21_nr_er_label": "Active",
    "tox21_nr_er_lbd": 0.011521476194086437,
    "tox21_nr_er_lbd_label": "Inactive",
    "tox21_nr_ppar_gamma": 0.006544924923972542,
    "tox21_nr_ppar_gamma_label": "Inactive",
    "tox21_sr_are": 0.4263520869224592,
    "tox21_sr_are_label": "Inactive",
    "tox21_sr_atad5": 0.009611791647503483,
    "tox21_sr_atad5_label": "Inactive",
    "tox21_sr_hse": 0.01144242418909213,
    "tox21_sr_hse_label": "Inactive",
    "tox21_sr_mmp": 0.09838402427253154,
    "tox21_sr_mmp_label": "Inactive",
    "tox21_sr_p53": 0.016654984205135608,
    "tox21_sr_p53_label": "Inactive",
    "clintox_fda_approved": 0.9795070081905697,
    "clintox_ct_tox": 0.06968909626110484,
    "hepatotoxicity_ml": 0.11137602642786995,
    "hepatotoxicity_level": "Low",
    "cardiotoxicity_ml": 0.2623680555974954,
    "cardiotoxicity_level": "Low",
    "nephrotoxicity_ml": 0.19274058618315723,
    "nephrotoxicity_level": "Low",
    "neurotoxicity_ml": 0.0947896955264967,
    "neurotoxicity_level": "Low",
    "ensemble_std": {
      "tox21_NR-AR": 0.1770816149862604,
      "tox21_NR-AR-LBD": 0.012494689902621172,
      "tox21_NR-AhR": 0.0009441118152507932,
      "tox21_NR-Aromatase": 0.34019506821379475,
      "tox21_NR-ER": 0.03191037245772799,
      "tox21_NR-ER-LBD": 0.006478523805913562,
      "tox21_NR-PPAR-gamma": 0.005455075076027458,
      "tox21_SR-ARE": 0.16717344810538304,
      "tox21_SR-ATAD5": 0.006388208352496517,
      "tox21_SR-HSE": 0.00255757581090787,
      "tox21_SR-MMP": 0.04361597572746845,
      "tox21_SR-p53": 0.00690011032203418,
      "clintox_FDA_APPROVED": 0.011373562244623714,
      "clintox_CT_TOX": 0.05822731376969146
    },
    "hepatotoxicity_factors": "High LogP (3.31); High MW (421)",
    "hepatotoxicity_confidence": 0.75,
    "cardiotoxicity_factors": "LogP in hERG range (3.31); MW in hERG range (421)",
    "cardiotoxicity_confidence": 0.7,
    "mutagenicity_ml": 0.0,
    "mutagenicity_level": "Low",
    "mutagenicity_factors": null,
    "mutagenicity_confidence": 0.8,
    "clinical_toxicity_ml": 0.15,
    "clinical_toxicity_level": "Low",
    "clinical_toxicity_confidence": 0.65,
    "carcinogenicity_ml": 0.0,
    "carcinogenicity_level": "Low",
    "carcinogenicity_factors": null,
    "carcinogenicity_confidence": 0.6,
    "nephrotoxicity_factors": null,
    "nephrotoxicity_confidence": 0.55,
    "neurotoxicity_factors": null,
    "neurotoxicity_confidence": 0.5,
    "ad_in_domain": false,
    "ad_status": "OUT_OF_DOMAIN",
    "ad_reliability_score": 0.36252927400468393,
    "ad_tanimoto_score": 0.9063231850117097,
    "ad_distance_score": 0.0,
    "ad_leverage_score": 0.0,
    "ad_warnings": null,
    "prediction_ci_lower": {
      "hepatotoxicity_ml": 0.022275205285574,
      "cardiotoxicity_ml": 0.05247361111949905,
      "nephrotoxicity_ml": 0.0385481172366314,
      "neurotoxicity_ml": 0.018957939105299346,
      "hepatotoxicity_confidence": 0.55,
      "cardiotoxicity_confidence": 0.4599999999999999,
      "mutagenicity_ml": 0.0,
      "mutagenicity_confidence": 0.6400000000000001,
      "carcinogenicity_ml": 0.0,
      "carcinogenicity_confidence": 0.2799999999999999,
      "nephrotoxicity_confidence": 0.19000000000000006,
      "neurotoxicity_confidence": 0.09999999999999998
    },
    "prediction_ci_upper": {
      "hepatotoxicity_ml": 0.2004768475701659,
      "cardiotoxicity_ml": 0.4722625000754917,
      "nephrotoxicity_ml": 0.3469330551296831,
      "neurotoxicity_ml": 0.17062145194769407,
      "hepatotoxicity_confidence": 0.95,
      "cardiotoxicity_confidence": 0.94,
      "mutagenicity_ml": 0.0,
      "mutagenicity_confidence": 0.96,
      "carcinogenicity_ml": 0.0,
      "carcinogenicity_confidence": 0.92,
      "nephrotoxicity_confidence": 0.91,
      "neurotoxicity_confidence": 0.9
    },
    "prediction_intervals": {
      "hepatotoxicity_ml": 0.1782016422845919,
      "cardiotoxicity_ml": 0.41978888895599265,
      "nephrotoxicity_ml": 0.30838493789305166,
      "neurotoxicity_ml": 0.1516635128423947,
      "hepatotoxicity_confidence": 0.3999999999999999,
      "cardiotoxicity_confidence": 0.48000000000000004,
      "mutagenicity_ml": 0.0,
      "mutagenicity_confidence": 0.31999999999999984,
      "carcinogenicity_ml": 0.0,
      "carcinogenicity_confidence": 0.6400000000000001,
      "nephrotoxicity_confidence": 0.72,
      "neurotoxicity_confidence": 0.8
    },
    "confidence_level": 0.9,
    "uncertainty_method": "split_conformal",
    "pri_score": 0.526,
    "pri_category": "moderate",
    "pri_ad_component": 0.3625,
    "pri_ensemble_component": 0.8287,
    "pri_conformal_component": 0.5251,
    "pri_performance_component": 0.4203,
    "pri_per_endpoint": {
      "tox21_nr_ar": 0.4753,
      "tox21_nr_ar_lbd": 0.5576,
      "tox21_nr_ahr": 0.5634,
      "tox21_nr_aromatase": 0.3937,
      "tox21_nr_er": 0.5479,
      "tox21_nr_er_lbd": 0.5606,
      "tox21_nr_ppar_gamma": 0.5611,
      "tox21_sr_are": 0.4802,
      "tox21_sr_atad5": 0.5606,
      "tox21_sr_hse": 0.5626,
      "tox21_sr_mmp": 0.542,
      "tox21_sr_p53": 0.5604,
      "clintox_fda_approved": 0.5581,
      "clintox_ct_tox": 0.5347,
      "hepatotoxicity_ml": 0.5032,
      "cardiotoxicity_ml": 0.4549
    },
    "pri_per_endpoint_category": {
      "tox21_nr_ar": "moderate",
      "tox21_nr_ar_lbd": "moderate",
      "tox21_nr_ahr": "moderate",
      "tox21_nr_aromatase": "low",
      "tox21_nr_er": "moderate",
      "tox21_nr_er_lbd": "moderate",
      "tox21_nr_ppar_gamma": "moderate",
      "tox21_sr_are": "moderate",
      "tox21_sr_atad5": "moderate",
      "tox21_sr_hse": "moderate",
      "tox21_sr_mmp": "moderate",
      "tox21_sr_p53": "moderate",
      "clintox_fda_approved": "moderate",
      "clintox_ct_tox": "moderate",
      "hepatotoxicity_ml": "moderate",
      "cardiotoxicity_ml": "moderate"
    },
    "pri_n_endpoints": 16,
    "pri_weights": {
      "ad_score": 0.3,
      "ensemble_uncertainty": 0.25,
      "conformal_width": 0.2,
      "model_performance": 0.25
    },
    "cds_score": 59.5,
    "cds_category": "moderate",
    "cds_traffic_light": "orange",
    "cds_drug_likeness": 75.0,
    "cds_metabolic_stability": 50.0,
    "cds_safety_profile": 60.0,
    "cds_permeability": 45.0,
    "cds_physicochemical": 60.0,
    "cds_optimization": "Improve Permeability (score: 45/100); Improve Metabolic stability (score: 50/100)",
    "cds_regulatory_risk": "low",
    "cds_regulatory_flags": "ICH S10: lipophilic with low TPSA \u2014 phototoxicity assessment recommended",
    "cds_benchmark_percentile": 66.7,
    "cds_benchmark_comparison": "MW: in IQR (420.5, range 270-450); Logp: in IQR (3.3, range 1.2-3.8); TPSA: in IQR (93.1, range 50-110); Rotatable Bonds: higher than typical (6, median=5)",
    "bcs_class": "II",
    "bcs_description": "Low solubility, high permeability - dissolution rate-limited absorption",
    "bcs_solubility_category": "low",
    "bcs_permeability_category": "high",
    "bcs_biowaiver_eligible": false,
    "bcs_development_risk": "moderate",
    "bcs_absorption_score": 56.1,
    "bcs_logS": -4.14,
    "bcs_solubility_mg_ml": 0.0307,
    "bcs_permeability_score": 0.805,
    "bcs_permeability_sources": "Descriptors",
    "bcs_logS_pH1.2": -4.14,
    "bcs_logS_pH4.5": -4.14,
    "bcs_logS_pH6.8": -4.14,
    "bcs_logS_pH7.4": -4.14,
    "bcs_ionization_type": "neutral",
    "bcs_formulation_strategies": "Amorphous solid dispersions (spray-dried or hot-melt extrusion); Nanocrystal/nanosuspension technology; Lipid-based drug delivery systems (SEDDS/SMEDDS); Cyclodextrin inclusion complexes",
    "bcs_formulation_considerations": "Dissolution is the rate-limiting step; Supersaturation maintenance is critical; Consider precipitation inhibitors (HPMC, PVP)",
    "bcs_recommended_excipients": "Solubilizers: Polysorbate 80, Cremophor EL; Polymeric Carriers: HPMC-AS, PVP-VA (Kollidon VA64); Lipid Carriers: Capryol 90, Gelucire 44/14",
    "metabolism_n_metabolites": 5,
    "metabolism_primary_cyps": "Esterases, CES1, CES2, CYP1A2, CYP2E1",
    "metabolism_reactive_risk": "low",
    "metabolism_liability_score": 28.0,
    "metabolism_soft_spots": "Ester hydrolysis (carboxylesterase-mediated); Terminal (omega) hydroxylation of alkyl chain; Epoxidation of olefinic double bond",
    "metabolism_reaction_types": "oxidation: 3; hydrolysis: 2",
    "metabolism_dili_risk": "low",
    "metabolite_1_smiles": "CC1C=CC2=CC(O)CC(O)C2C1CCC1CC(O)CC(=O)O1",
    "metabolite_1_reaction": "Ester hydrolysis (carboxylesterase-mediated)",
    "metabolite_1_cyps": "Esterases, CES1, CES2",
    "metabolite_1_priority": 2,
    "metabolite_2_smiles": "CCC(C)(C)C(=O)OC1CC(O)C=C2C=CC(C)C(CCC(O)CCO)C21",
    "metabolite_2_reaction": "Ester hydrolysis (carboxylesterase-mediated)",
    "metabolite_2_cyps": "Esterases, CES1, CES2",
    "metabolite_2_priority": 2,
    "metabolite_3_smiles": "CC1C=CC2=CC(O)CC(OC(=O)C(C)(C)CCO)C2C1CCC1CC(O)CC(=O)O1",
    "metabolite_3_reaction": "Terminal (omega) hydroxylation of alkyl chain",
    "metabolite_3_cyps": "CYP4A11, CYP3A4",
    "metabolite_3_priority": 3,
    "metabolite_4_smiles": "CCC(C)(C)C(=O)OC1CC(O)C2OC23C=CC(C)C(CCC2CC(O)CC(=O)O2)C13",
    "metabolite_4_reaction": "Epoxidation of olefinic double bond",
    "metabolite_4_cyps": "CYP1A2, CYP2E1",
    "metabolite_4_priority": 4,
    "metabolite_5_smiles": "CCC(C)(C)C(=O)OC1CC(O)C=C2C3OC3C(C)C(CCC3CC(O)CC(=O)O3)C21",
    "metabolite_5_reaction": "Epoxidation of olefinic double bond",
    "metabolite_5_cyps": "CYP1A2, CYP2E1",
    "metabolite_5_priority": 4,
    "cyp3a4_inhibitor": 0.44999999999999996,
    "cyp2d6_inhibitor": 0.2,
    "cyp2c9_inhibitor": 0.25,
    "cyp2c19_inhibitor": 0.2,
    "cyp1a2_inhibitor": 0.15000000000000002,
    "ddi_risk_score": 10.5,
    "ddi_risk_category": "low",
    "ddi_n_cyp_interactions": 1,
    "ddi_max_inhibition": "weak",
    "ddi_primary_pathway": "CYP3A4 (weak inhibitor, P=0.45)",
    "ddi_pgp_risk": "minimal",
    "ddi_perpetrator_role": "none",
    "ddi_victim_role": "none",
    "ddi_cyp1_enzyme": "CYP3A4",
    "ddi_cyp1_prob": 0.45,
    "ddi_cyp1_strength": "weak",
    "ddi_cyp1_at_risk": "Midazolam, Triazolam, Simvastatin, Lovastatin",
    "ddi_cyp2_enzyme": "CYP2C9",
    "ddi_cyp2_prob": 0.25,
    "ddi_cyp2_strength": "unlikely",
    "ddi_cyp2_at_risk": "Warfarin (S), Phenytoin, Celecoxib, Losartan",
    "ddi_cyp3_enzyme": "CYP2C19",
    "ddi_cyp3_prob": 0.2,
    "ddi_cyp3_strength": "unlikely",
    "ddi_cyp3_at_risk": "Omeprazole, Clopidogrel, Diazepam, Citalopram",
    "comparative_n_similar": 1,
    "comparative_drug_space_score": 100.0,
    "comparative_within_drug_space": true,
    "comparative_most_similar": "Pioglitazone",
    "comparative_similarity": 0.133,
    "comparative_drug_1_name": "Pioglitazone",
    "comparative_drug_1_class": "Thiazolidinedione",
    "comparative_drug_1_similarity": 0.133,
    "comparative_drug_1_bcs": "II",
    "comparative_strengths": "LogP in optimal range (3.3); Molecular weight in optimal range (420.5); TPSA in optimal range (93.1); Strong Drug-likeness profile (score: 75/100)",
    "comparative_weaknesses": "Weak Safety profile (score: 35/100)",
    "bro5_compound_class": "ro5_compliant",
    "bro5_is_bro5": false,
    "bro5_ro5_violations": 0,
    "bro5_drug_likeness": 100.0,
    "bro5_oral_bioavailability_risk": "low",
    "bro5_recommendations": "Ro5-compliant: standard oral formulation approaches applicable",
    "aop_n_triggered": 4,
    "aop_risk_score": 32.8,
    "aop_risk_category": "moderate",
    "aop_organs_at_risk": "reproductive, liver, kidney",
    "aop_highest_concern": "AOP:200: Male reproductive toxicity (confidence=0.56)",
    "aop_1_id": "AOP:200",
    "aop_1_name": "Androgen receptor antagonism leading to male reproductive dysfunction",
    "aop_1_outcome": "Male reproductive toxicity",
    "aop_1_organ": "reproductive",
    "aop_1_confidence": 0.562,
    "aop_1_mie": "Androgen receptor (AR) antagonism/binding",
    "aop_2_id": "AOP:25",
    "aop_2_name": "Mitochondrial dysfunction leading to liver injury",
    "aop_2_outcome": "Drug-induced liver injury (DILI)",
    "aop_2_organ": "liver",
    "aop_2_confidence": 0.51,
    "aop_2_mie": "Inhibition of mitochondrial complex I/III",
    "aop_3_id": "AOP:29",
    "aop_3_name": "Estrogen receptor agonism leading to reproductive effects",
    "aop_3_outcome": "Reproductive/developmental toxicity",
    "aop_3_organ": "reproductive",
    "aop_3_confidence": 0.486,
    "aop_3_mie": "Estrogen receptor (ER) activation",
    "aop_4_id": "AOP:NEPHRO_ROS",
    "aop_4_name": "Reactive oxygen species generation leading to glomerular injury",
    "aop_4_outcome": "Glomerulonephritis / Chronic kidney disease",
    "aop_4_organ": "kidney",
    "aop_4_confidence": 0.45,
    "aop_4_mie": "Mitochondrial electron transport chain disruption in podocytes"
  },
  "Cyclosporine A": {
    "success": true,
    "compound_id": "Cyclosporine A",
    "smiles": "CCC1NC(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C(O)C(C)CC=CC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)N(C)C(=O)C(C(C)CC)N(C)C(=O)CN(C)C(=O)C(C(C)C)N(C)C1=O",
    "prediction_engine": "RDKit + Trained ML Models",
    "molecular_weight": 1159.61,
    "logp": 4.4,
    "tpsa": 249.7,
    "num_hbd": 4,
    "num_hba": 11,
    "num_rotatable_bonds": 16,
    "num_aromatic_rings": 0,
    "num_heavy_atoms": 82,
    "num_aliphatic_rings": 1,
    "num_saturated_rings": 1,
    "fraction_csp3": 0.803,
    "molar_refractivity": 320.004,
    "qed_score": 0.158,
    "synthetic_accessibility": 2.11,
    "lipinski_pass": false,
    "lipinski_violations": 2,
    "lipinski_details": "Fail (2 violations: MW: 1159.61 > 500; HBA: 11 > 10)",
    "veber_pass": false,
    "veber_details": "Fail (Rotatable bonds: 16 > 10; TPSA: 249.7 > 140)",
    "ghose_pass": false,
    "ghose_details": "Fail (MW: 1159.61 (range: 160-480); MR: 320.004 (range: 40-130); Heavy atoms: 82 (range: 20-70))",
    "egan_pass": false,
    "egan_details": "Fail (TPSA: 249.7 > 132)",
    "muegge_pass": false,
    "muegge_details": "Fail (MW: 1159.61 (range: 200-600); TPSA: 249.7 > 150; Aromatic rings: 0 (range: 2-7); Rotatable bonds: 16 > 15; HBA: 11 > 10)",
    "pains_alert": false,
    "brenk_alert": true,
    "prediction_warnings": "Brenk alerts: 1",
    "caco2_permeability_category": "Low",
    "human_intestinal_absorption_category": "Poor",
    "bbb_permeability_category": "Low",
    "cns_permeability_category": "Low",
    "overall_drug_likeness": "Poor",
    "overall_safety_profile": "Concerning",
    "ml_model_version": "1.0.0",
    "ml_model_name": "sklearn_ensemble",
    "ml_model_auc": 0.7101480926110298,
    "tox21_nr_ar": 0.034999323635787775,
    "tox21_nr_ar_label": "Inactive",
    "tox21_nr_ar_lbd": 0.015501037753030194,
    "tox21_nr_ar_lbd_label": "Inactive",
    "tox21_nr_ahr": 0.039520204592782764,
    "tox21_nr_ahr_label": "Inactive",
    "tox21_nr_aromatase": 0.031573210586169645,
    "tox21_nr_aromatase_label": "Inactive",
    "tox21_nr_er": 0.08012116658498675,
    "tox21_nr_er_label": "Inactive",
    "tox21_nr_er_lbd": 0.021928514045490552,
    "tox21_nr_er_lbd_label": "Inactive",
    "tox21_nr_ppar_gamma": 0.019769264254420393,
    "tox21_nr_ppar_gamma_label": "Inactive",
    "tox21_sr_are": 0.0735884156385185,
    "tox21_sr_are_label": "Inactive",
    "tox21_sr_atad5": 0.04074499091441667,
    "tox21_sr_atad5_label": "Inactive",
    "tox21_sr_hse": 0.04194355874068919,
    "tox21_sr_hse_label": "Inactive",
    "tox21_sr_mmp": 0.029820247220104023,
    "tox21_sr_mmp_label": "Inactive",
    "tox21_sr_p53": 0.06066211547488375,
    "tox21_sr_p53_label": "Inactive",
    "clintox_fda_approved": 0.969167909755678,
    "clintox_ct_tox": 0.7035039265620575,
    "hepatotoxicity_ml": 0.044672049436141885,
    "hepatotoxicity_level": "Low",
    "cardiotoxicity_ml": 0.051704331429311266,
    "cardiotoxicity_level": "Low",
    "nephrotoxicity_ml": 0.05284957323024402,
    "nephrotoxicity_level": "Low",
    "neurotoxicity_ml": 0.04305362085824069,
    "neurotoxicity_level": "Low",
    "ensemble_std": {
      "tox21_NR-AR": 0.021000676364212226,
      "tox21_NR-AR-LBD": 0.014498962246969805,
      "tox21_NR-AhR": 0.03200453989350018,
      "tox21_NR-Aromatase": 0.028185818218169546,
      "tox21_NR-ER": 0.05759847309078037,
      "tox21_NR-ER-LBD": 0.016071485954509447,
      "tox21_NR-PPAR-gamma": 0.018230735745579606,
      "tox21_SR-ARE": 0.05532088274149366,
      "tox21_SR-ATAD5": 0.01925500908558333,
      "tox21_SR-HSE": 0.020010507462825317,
      "tox21_SR-MMP": 0.021050516262688484,
      "tox21_SR-p53": 0.05063292557316134,
      "clintox_FDA_APPROVED": 0.024983305464652827,
      "clintox_CT_TOX": 0.18014429763556256
    },
    "hepatotoxicity_factors": "High LogP (4.40); High MW (1160)",
    "hepatotoxicity_confidence": 0.75,
    "cardiotoxicity_factors": "LogP in hERG range (4.40); Basic nitrogen atoms (10)",
    "cardiotoxicity_confidence": 0.7,
    "mutagenicity_ml": 0.3,
    "mutagenicity_level": "Low",
    "mutagenicity_factors": "Brenk alerts (1)",
    "mutagenicity_confidence": 0.8,
    "clinical_toxicity_ml": 0.25,
    "clinical_toxicity_level": "Low",
    "clinical_toxicity_confidence": 0.65,
    "carcinogenicity_ml": 0.2,
    "carcinogenicity_level": "Low",
    "carcinogenicity_factors": "Toxic structural alerts",
    "carcinogenicity_confidence": 0.6,
    "nephrotoxicity_factors": "High MW (1160)",
    "nephrotoxicity_confidence": 0.55,
    "neurotoxicity_factors": "CNS-active structure (basic amine)",
    "neurotoxicity_confidence": 0.5,
    "ad_in_domain": false,
    "ad_status": "OUT_OF_DOMAIN",
    "ad_reliability_score": 0.1285714285714286,
    "ad_tanimoto_score": 0.32142857142857145,
    "ad_distance_score": 0.0,
    "ad_leverage_score": 0.0,
    "ad_warnings": null,
    "prediction_ci_lower": {
      "hepatotoxicity_ml": 0.008934409887228371,
      "cardiotoxicity_ml": 0.010340866285862269,
      "nephrotoxicity_ml": 0.010569914646048797,
      "neurotoxicity_ml": 0.008610724171648113,
      "hepatotoxicity_confidence": 0.55,
      "cardiotoxicity_confidence": 0.4599999999999999,
      "mutagenicity_ml": 0.06,
      "mutagenicity_confidence": 0.6400000000000001,
      "carcinogenicity_ml": 0.03999999999999998,
      "carcinogenicity_confidence": 0.2799999999999999,
      "nephrotoxicity_confidence": 0.19000000000000006,
      "neurotoxicity_confidence": 0.09999999999999998
    },
    "prediction_ci_upper": {
      "hepatotoxicity_ml": 0.0804096889850554,
      "cardiotoxicity_ml": 0.09306779657276026,
      "nephrotoxicity_ml": 0.09512923181443925,
      "neurotoxicity_ml": 0.07749651754483326,
      "hepatotoxicity_confidence": 0.95,
      "cardiotoxicity_confidence": 0.94,
      "mutagenicity_ml": 0.54,
      "mutagenicity_confidence": 0.96,
      "carcinogenicity_ml": 0.36000000000000004,
      "carcinogenicity_confidence": 0.92,
      "nephrotoxicity_confidence": 0.91,
      "neurotoxicity_confidence": 0.9
    },
    "prediction_intervals": {
      "hepatotoxicity_ml": 0.07147527909782703,
      "cardiotoxicity_ml": 0.082726930286898,
      "nephrotoxicity_ml": 0.08455931716839045,
      "neurotoxicity_ml": 0.06888579337318515,
      "hepatotoxicity_confidence": 0.3999999999999999,
      "cardiotoxicity_confidence": 0.48000000000000004,
      "mutagenicity_ml": 0.48000000000000004,
      "mutagenicity_confidence": 0.31999999999999984,
      "carcinogenicity_ml": 0.32000000000000006,
      "carcinogenicity_confidence": 0.6400000000000001,
      "nephrotoxicity_confidence": 0.72,
      "neurotoxicity_confidence": 0.8
    },
    "confidence_level": 0.9,
    "uncertainty_method": "split_conformal",
    "pri_score": 0.4711,
    "pri_category": "moderate",
    "pri_ad_component": 0.1286,
    "pri_ensemble_component": 0.8676,
    "pri_conformal_component": 0.5529,
    "pri_performance_component": 0.4203,
    "pri_per_endpoint": {
      "tox21_nr_ar": 0.4831,
      "tox21_nr_ar_lbd": 0.4864,
      "tox21_nr_ahr": 0.4776,
      "tox21_nr_aromatase": 0.4796,
      "tox21_nr_er": 0.4648,
      "tox21_nr_er_lbd": 0.4856,
      "tox21_nr_ppar_gamma": 0.4845,
      "tox21_sr_are": 0.466,
      "tox21_sr_atad5": 0.484,
      "tox21_sr_hse": 0.4836,
      "tox21_sr_mmp": 0.4831,
      "tox21_sr_p53": 0.4683,
      "clintox_fda_approved": 0.4812,
      "clintox_ct_tox": 0.4036,
      "hepatotoxicity_ml": 0.4544,
      "cardiotoxicity_ml": 0.4521
    },
    "pri_per_endpoint_category": {
      "tox21_nr_ar": "moderate",
      "tox21_nr_ar_lbd": "moderate",
      "tox21_nr_ahr": "moderate",
      "tox21_nr_aromatase": "moderate",
      "tox21_nr_er": "moderate",
      "tox21_nr_er_lbd": "moderate",
      "tox21_nr_ppar_gamma": "moderate",
      "tox21_sr_are": "moderate",
      "tox21_sr_atad5": "moderate",
      "tox21_sr_hse": "moderate",
      "tox21_sr_mmp": "moderate",
      "tox21_sr_p53": "moderate",
      "clintox_fda_approved": "moderate",
      "clintox_ct_tox": "low",
      "hepatotoxicity_ml": "moderate",
      "cardiotoxicity_ml": "moderate"
    },
    "pri_n_endpoints": 16,
    "pri_weights": {
      "ad_score": 0.3,
      "ensemble_uncertainty": 0.25,
      "conformal_width": 0.2,
      "model_performance": 0.25
    },
    "cds_score": 30.8,
    "cds_category": "poor",
    "cds_traffic_light": "red",
    "cds_drug_likeness": 35.6,
    "cds_metabolic_stability": 30.0,
    "cds_safety_profile": 49.0,
    "cds_permeability": 30.0,
    "cds_physicochemical": 0,
    "cds_critical_liabilities": "Unfavorable physicochemical properties",
    "cds_optimization": "Improve Physicochemical (score: 0/100);   - Address: Very high MW (1160 Da); Improve Metabolic stability (score: 30/100);   - Address: High MW (1160) \u2014 increased metabolic sites; Improve Permeability (score: 30/100)",
    "cds_regulatory_risk": "low",
    "cds_regulatory_flags": "Regulatory: 2 Ro5 violations \u2014 bioavailability justification needed",
    "cds_benchmark_percentile": 23.9,
    "cds_benchmark_comparison": "MW: outside typical range (1159.6); Logp: acceptable (4.4); TPSA: outside typical range (249.7); Rotatable Bonds: higher than typical (16, median=5)",
    "bcs_class": "IV",
    "bcs_description": "Low solubility, low permeability - significant formulation challenges",
    "bcs_solubility_category": "low",
    "bcs_permeability_category": "low",
    "bcs_biowaiver_eligible": false,
    "bcs_development_risk": "high",
    "bcs_absorption_score": 14.4,
    "bcs_logS": -8.75,
    "bcs_solubility_mg_ml": 0.0,
    "bcs_permeability_score": 0.404,
    "bcs_permeability_sources": "Descriptors",
    "bcs_logS_pH1.2": -8.75,
    "bcs_logS_pH4.5": -8.75,
    "bcs_logS_pH6.8": -8.75,
    "bcs_logS_pH7.4": -8.75,
    "bcs_ionization_type": "neutral",
    "bcs_formulation_strategies": "Amorphous nanoparticle formulations; Lipid nanoparticles (SLN, NLC); Polymeric micelles or nanocapsules; Prodrug strategy (improve both S and P)",
    "bcs_formulation_considerations": "Both dissolution AND permeation are rate-limiting; Oral bioavailability typically <30%; Advanced formulation technology required",
    "bcs_recommended_excipients": "Nanocarriers: PLGA nanoparticles, Lipid nanocapsules; Complexation: HP-\u03b2-cyclodextrin, SBE-\u03b2-cyclodextrin (Captisol); Advanced Lipids: Self-emulsifying systems, Microemulsions",
    "metabolism_n_metabolites": 25,
    "metabolism_primary_cyps": "CYP3A4, CYP2D6, CYP2C19, FMO3, CYP4A11",
    "metabolism_reactive_risk": "low",
    "metabolism_liability_score": 70.0,
    "metabolism_soft_spots": "N-demethylation (removal of N-CH3); N-dealkylation (general alkyl removal); Allylic hydroxylation (alpha to double bond); Terminal (omega) hydroxylation of alkyl chain; N-oxidation of tertiary amine",
    "metabolism_reaction_types": "dealkylation: 8; oxidation: 7",
    "metabolism_dili_risk": "low",
    "metabolite_1_smiles": "CC=CCC(C)C(O)C1C(=O)N(C)C(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC)C(=O)N(C)C(C(C)C)C(=O)N(C)CC(=O)N(C)C(C(C)CC)C(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)N1C",
    "metabolite_1_reaction": "N-demethylation (removal of N-CH3)",
    "metabolite_1_cyps": "CYP3A4, CYP2D6, CYP2C19",
    "metabolite_1_priority": 1,
    "metabolite_2_smiles": "CC=CCC(C)C(O)C1C(=O)NC(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(CC)C(=O)N(C)C(C(C)C)C(=O)N(C)CC(=O)N(C)C(C(C)CC)C(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)N1C",
    "metabolite_2_reaction": "N-demethylation (removal of N-CH3)",
    "metabolite_2_cyps": "CYP3A4, CYP2D6, CYP2C19",
    "metabolite_2_priority": 1,
    "metabolite_3_smiles": "CC=CCC(C)C(O)C1NC(=O)C(C(C)C)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)N(C)C(=O)C(C(C)CC)N(C)C(=O)CN(C)C(=O)C(C(C)C)N(C)C(=O)C(CC)NC(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C1=O",
    "metabolite_3_reaction": "N-demethylation (removal of N-CH3)",
    "metabolite_3_cyps": "CYP3A4, CYP2D6, CYP2C19",
    "metabolite_3_priority": 1,
    "metabolite_4_smiles": "CC=CCC(C)C(O)C1C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(CC)C(=O)N(C)C(C(C)C)C(=O)N(C)CC(=O)N(C)C(C(C)CC)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)N1C",
    "metabolite_4_reaction": "N-demethylation (removal of N-CH3)",
    "metabolite_4_cyps": "CYP3A4, CYP2D6, CYP2C19",
    "metabolite_4_priority": 1,
    "metabolite_5_smiles": "CC=CCC(C)C(O)C1C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(CC)C(=O)N(C)C(C(C)C)C(=O)N(C)CC(=O)NC(C(C)CC)C(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)N1C",
    "metabolite_5_reaction": "N-demethylation (removal of N-CH3)",
    "metabolite_5_cyps": "CYP3A4, CYP2D6, CYP2C19",
    "metabolite_5_priority": 1,
    "cyp3a4_inhibitor": 0.5499999999999999,
    "cyp2d6_inhibitor": 0.25,
    "cyp2c9_inhibitor": 0.25,
    "cyp2c19_inhibitor": 0.30000000000000004,
    "cyp1a2_inhibitor": 0.1,
    "ddi_risk_score": 37.1,
    "ddi_risk_category": "moderate",
    "ddi_n_cyp_interactions": 2,
    "ddi_max_inhibition": "moderate",
    "ddi_moderate_inhibitions": "CYP3A4",
    "ddi_primary_pathway": "CYP3A4 (moderate inhibitor, P=0.55)",
    "ddi_pgp_risk": "minimal",
    "ddi_clinical_warnings": "Moderate CYP3A4 inhibitor - 2-5 fold AUC increase in CYP3A4 substrates",
    "ddi_monitoring": "Caution with narrow TI CYP3A4 substrates: Tacrolimus, Cyclosporine",
    "ddi_induction_risk": "Possible PXR activation (high LogP + MW profile)",
    "ddi_perpetrator_role": "weak_perpetrator",
    "ddi_victim_role": "none",
    "ddi_known_interactions": "Sildenafil (CYP3A4 moderate inhibition): Hypotension \u2014 reduce dose to 25mg; Apixaban (CYP3A4 moderate inhibition): Bleeding risk \u2014 dose adjustment",
    "ddi_cyp1_enzyme": "CYP3A4",
    "ddi_cyp1_prob": 0.55,
    "ddi_cyp1_strength": "moderate",
    "ddi_cyp1_at_risk": "Midazolam, Triazolam, Simvastatin, Lovastatin",
    "ddi_cyp2_enzyme": "CYP2C19",
    "ddi_cyp2_prob": 0.3,
    "ddi_cyp2_strength": "weak",
    "ddi_cyp2_at_risk": "Omeprazole, Clopidogrel, Diazepam, Citalopram",
    "ddi_cyp3_enzyme": "CYP2C9",
    "ddi_cyp3_prob": 0.25,
    "ddi_cyp3_strength": "unlikely",
    "ddi_cyp3_at_risk": "Warfarin (S), Phenytoin, Celecoxib, Losartan",
    "comparative_n_similar": 1,
    "comparative_drug_space_score": 33.3,
    "comparative_within_drug_space": false,
    "comparative_most_similar": "Mycophenolate mofetil",
    "comparative_similarity": 0.108,
    "comparative_drug_1_name": "Mycophenolate mofetil",
    "comparative_drug_1_class": "Immunosuppressant",
    "comparative_drug_1_similarity": 0.108,
    "comparative_drug_1_bcs": "II",
    "comparative_strengths": "LogP in optimal range (4.4)",
    "comparative_weaknesses": "Molecular weight too high (1159.6, optimal: 150-500); TPSA too high (249.7, optimal: 20-140); Weak Absorption profile (score: 18/100); Higher LogP than similar drugs (4.4 vs avg 2.5 in Mycophenolate mofetil); Higher MW than similar drugs (1159.6 vs avg 433.5 in Mycophenolate mofetil)",
    "bro5_compound_class": "protac_like",
    "bro5_is_bro5": true,
    "bro5_ro5_violations": 2,
    "bro5_drug_likeness": 65.0,
    "bro5_oral_bioavailability_risk": "moderate",
    "bro5_violation_details": "MW=1160 (>500); HBA=11 (>10)",
    "bro5_is_macrocycle": true,
    "bro5_macrocycle_ring_size": 30,
    "bro5_fsp3": 0.803,
    "bro5_n_rotatable_bonds": 16,
    "bro5_chameleonicity": 0.759,
    "bro5_description": "PROTAC-like bifunctional molecule (MW=1160, NRotB=16)",
    "bro5_protac_peg_units": 0,
    "bro5_protac_alkyl_chain_segments": 0,
    "bro5_protac_linker_type": "Mixed/rigid",
    "bro5_protac_flexibility": "moderately flexible",
    "bro5_protac_assessment": "Strengths: Good Fsp3 supports 3D shape diversity; Chameleonic character may enable cell permeability",
    "bro5_recommendations": "N-methylation of backbone NH groups may reduce TPSA and improve membrane permeability; Macrocyclic compound: may exhibit chameleonic behavior enabling oral bioavailability despite bRo5 properties (Driggers et al., 2008); PROTAC optimization: explore shorter/rigid linkers to reduce MW and improve oral exposure",
    "aop_n_triggered": 2,
    "aop_risk_score": 18.4,
    "aop_risk_category": "low",
    "aop_organs_at_risk": "liver, kidney",
    "aop_highest_concern": "AOP:25: Drug-induced liver injury (DILI) (confidence=0.51)",
    "aop_1_id": "AOP:25",
    "aop_1_name": "Mitochondrial dysfunction leading to liver injury",
    "aop_1_outcome": "Drug-induced liver injury (DILI)",
    "aop_1_organ": "liver",
    "aop_1_confidence": 0.51,
    "aop_1_mie": "Inhibition of mitochondrial complex I/III",
    "aop_2_id": "AOP:NEPHRO_ROS",
    "aop_2_name": "Reactive oxygen species generation leading to glomerular injury",
    "aop_2_outcome": "Glomerulonephritis / Chronic kidney disease",
    "aop_2_organ": "kidney",
    "aop_2_confidence": 0.45,
    "aop_2_mie": "Mitochondrial electron transport chain disruption in podocytes"
  },
  "ARV-110": {
    "success": true,
    "compound_id": "ARV-110",
    "smiles": "CC(C)c1cc(NC(=O)COc2ccc(-c3cnc4cc(F)c(OCC5CCN(CC6CC(=O)NC(=O)C6)C5)cc4n3)cc2)ccc1F",
    "prediction_engine": "RDKit + Trained ML Models",
    "molecular_weight": 657.718,
    "logp": 5.469,
    "tpsa": 122.75,
    "num_hbd": 2,
    "num_hba": 8,
    "num_rotatable_bonds": 11,
    "num_aromatic_rings": 4,
    "num_heavy_atoms": 48,
    "num_aliphatic_rings": 2,
    "num_saturated_rings": 2,
    "fraction_csp3": 0.361,
    "molar_refractivity": 175.461,
    "qed_score": 0.204,
    "synthetic_accessibility": 1.76,
    "lipinski_pass": false,
    "lipinski_violations": 2,
    "lipinski_details": "Fail (2 violations: MW: 657.718 > 500; LogP: 5.469 > 5)",
    "veber_pass": false,
    "veber_details": "Fail (Rotatable bonds: 11 > 10)",
    "ghose_pass": false,
    "ghose_details": "Fail (MW: 657.718 (range: 160-480); MR: 175.461 (range: 40-130))",
    "egan_pass": true,
    "egan_details": "Pass",
    "muegge_pass": false,
    "muegge_details": "Fail (MW: 657.718 (range: 200-600); LogP: 5.469 (range: -2 to 5))",
    "pains_alert": false,
    "brenk_alert": true,
    "prediction_warnings": "Brenk alerts: 1",
    "caco2_permeability_category": "Medium",
    "human_intestinal_absorption_category": "Poor",
    "bbb_permeability_category": "Medium",
    "cns_permeability_category": "Low",
    "overall_drug_likeness": "Poor",
    "overall_safety_profile": "Concerning",
    "ml_model_version": "1.0.0",
    "ml_model_name": "sklearn_ensemble",
    "ml_model_auc": 0.7101480926110298,
    "tox21_nr_ar": 0.030542681949799026,
    "tox21_nr_ar_label": "Inactive",
    "tox21_nr_ar_lbd": 0.030437495076465947,
    "tox21_nr_ar_lbd_label": "Inactive",
    "tox21_nr_ahr": 0.36241621549788605,
    "tox21_nr_ahr_label": "Inactive",
    "tox21_nr_aromatase": 0.03581565190319405,
    "tox21_nr_aromatase_label": "Inactive",
    "tox21_nr_er": 0.10904882350316064,
    "tox21_nr_er_label": "Inactive",
    "tox21_nr_er_lbd": 0.028916780201416126,
    "tox21_nr_er_lbd_label": "Inactive",
    "tox21_nr_ppar_gamma": 0.021568532718697568,
    "tox21_nr_ppar_gamma_label": "Inactive",
    "tox21_sr_are": 0.11890930389249367,
    "tox21_sr_are_label": "Inactive",
    "tox21_sr_atad5": 0.04426295327304862,
    "tox21_sr_atad5_label": "Inactive",
    "tox21_sr_hse": 0.04048549552000157,
    "tox21_sr_hse_label": "Inactive",
    "tox21_sr_mmp": 0.09514792696045363,
    "tox21_sr_mmp_label": "Inactive",
    "tox21_sr_p53": 0.4668159991114346,
    "tox21_sr_p53_label": "Inactive",
    "clintox_fda_approved": 0.723575209773136,
    "clintox_ct_tox": 0.24043360825454774,
    "hepatotoxicity_ml": 0.2129715956361931,
    "hepatotoxicity_level": "Low",
    "cardiotoxicity_ml": 0.10702861542647366,
    "cardiotoxicity_level": "Low",
    "nephrotoxicity_ml": 0.1963814269244129,
    "nephrotoxicity_level": "Low",
    "neurotoxicity_ml": 0.14639735463045953,
    "neurotoxicity_level": "Low",
    "ensemble_std": {
      "tox21_NR-AR": 0.023457318050200973,
      "tox21_NR-AR-LBD": 0.02956250492353405,
      "tox21_NR-AhR": 0.12041621549788603,
      "tox21_NR-Aromatase": 0.02393087887843035,
      "tox21_NR-ER": 0.033924421529951926,
      "tox21_NR-ER-LBD": 0.021083219798583876,
      "tox21_NR-PPAR-gamma": 0.018431467281302433,
      "tox21_SR-ARE": 0.0690078722523904,
      "tox21_SR-ATAD5": 0.027737046726951375,
      "tox21_SR-HSE": 0.027514504479998432,
      "tox21_SR-MMP": 0.036035887073123656,
      "tox21_SR-p53": 0.3550731685571336,
      "clintox_FDA_APPROVED": 0.06974432922648727,
      "clintox_CT_TOX": 0.08861941387343653
    },
    "hepatotoxicity_factors": "High LogP (5.47); High MW (658); Multiple aromatic rings (4)",
    "hepatotoxicity_confidence": 0.75,
    "cardiotoxicity_factors": "Basic nitrogen atoms (5); Multiple aromatic rings (4)",
    "cardiotoxicity_confidence": 0.7,
    "mutagenicity_ml": 0.3,
    "mutagenicity_level": "Low",
    "mutagenicity_factors": "Brenk alerts (1)",
    "mutagenicity_confidence": 0.8,
    "clinical_toxicity_ml": 0.1,
    "clinical_toxicity_level": "Low",
    "clinical_toxicity_confidence": 0.65,
    "carcinogenicity_ml": 0.65,
    "carcinogenicity_level": "Medium",
    "carcinogenicity_factors": "High bioaccumulation potential (LogP=5.47); Polycyclic aromatic structure (4 rings); Toxic structural alerts",
    "carcinogenicity_confidence": 0.6,
    "nephrotoxicity_factors": "High MW (658)",
    "nephrotoxicity_confidence": 0.55,
    "neurotoxicity_factors": "CNS-active structure (basic amine)",
    "neurotoxicity_confidence": 0.5,
    "ad_in_domain": false,
    "ad_status": "OUT_OF_DOMAIN",
    "ad_reliability_score": 0.16666666666666669,
    "ad_tanimoto_score": 0.4166666666666667,
    "ad_distance_score": 0.0,
    "ad_leverage_score": 0.0,
    "ad_warnings": null,
    "prediction_ci_lower": {
      "hepatotoxicity_ml": 0.0425943191272386,
      "cardiotoxicity_ml": 0.021405723085294703,
      "nephrotoxicity_ml": 0.039276285384882564,
      "neurotoxicity_ml": 0.029279470926091872,
      "hepatotoxicity_confidence": 0.55,
      "cardiotoxicity_confidence": 0.4599999999999999,
      "mutagenicity_ml": 0.06,
      "mutagenicity_confidence": 0.6400000000000001,
      "carcinogenicity_ml": 0.37000000000000005,
      "carcinogenicity_confidence": 0.2799999999999999,
      "nephrotoxicity_confidence": 0.19000000000000006,
      "neurotoxicity_confidence": 0.09999999999999998
    },
    "prediction_ci_upper": {
      "hepatotoxicity_ml": 0.3833488721451476,
      "cardiotoxicity_ml": 0.1926515077676526,
      "nephrotoxicity_ml": 0.3534865684639432,
      "neurotoxicity_ml": 0.26351523833482715,
      "hepatotoxicity_confidence": 0.95,
      "cardiotoxicity_confidence": 0.94,
      "mutagenicity_ml": 0.54,
      "mutagenicity_confidence": 0.96,
      "carcinogenicity_ml": 0.9299999999999999,
      "carcinogenicity_confidence": 0.92,
      "nephrotoxicity_confidence": 0.91,
      "neurotoxicity_confidence": 0.9
    },
    "prediction_intervals": {
      "hepatotoxicity_ml": 0.340754553017909,
      "cardiotoxicity_ml": 0.1712457846823579,
      "nephrotoxicity_ml": 0.3142102830790606,
      "neurotoxicity_ml": 0.23423576740873528,
      "hepatotoxicity_confidence": 0.3999999999999999,
      "cardiotoxicity_confidence": 0.48000000000000004,
      "mutagenicity_ml": 0.48000000000000004,
      "mutagenicity_confidence": 0.31999999999999984,
      "carcinogenicity_ml": 0.5599999999999998,
      "carcinogenicity_confidence": 0.6400000000000001,
      "nephrotoxicity_confidence": 0.72,
      "neurotoxicity_confidence": 0.8
    },
    "confidence_level": 0.9,
    "uncertainty_method": "split_conformal",
    "pri_score": 0.466,
    "pri_category": "moderate",
    "pri_ad_component": 0.1667,
    "pri_ensemble_component": 0.8194,
    "pri_conformal_component": 0.5305,
    "pri_performance_component": 0.4203,
    "pri_per_endpoint": {
      "tox21_nr_ar": 0.4933,
      "tox21_nr_ar_lbd": 0.4903,
      "tox21_nr_ahr": 0.4449,
      "tox21_nr_aromatase": 0.4931,
      "tox21_nr_er": 0.4881,
      "tox21_nr_er_lbd": 0.4945,
      "tox21_nr_ppar_gamma": 0.4959,
      "tox21_sr_are": 0.4706,
      "tox21_sr_atad5": 0.4912,
      "tox21_sr_hse": 0.4913,
      "tox21_sr_mmp": 0.4871,
      "tox21_sr_p53": 0.3275,
      "clintox_fda_approved": 0.4702,
      "clintox_ct_tox": 0.4608,
      "hepatotoxicity_ml": 0.4119,
      "cardiotoxicity_ml": 0.4458
    },
    "pri_per_endpoint_category": {
      "tox21_nr_ar": "moderate",
      "tox21_nr_ar_lbd": "moderate",
      "tox21_nr_ahr": "low",
      "tox21_nr_aromatase": "moderate",
      "tox21_nr_er": "moderate",
      "tox21_nr_er_lbd": "moderate",
      "tox21_nr_ppar_gamma": "moderate",
      "tox21_sr_are": "moderate",
      "tox21_sr_atad5": "moderate",
      "tox21_sr_hse": "moderate",
      "tox21_sr_mmp": "moderate",
      "tox21_sr_p53": "low",
      "clintox_fda_approved": "moderate",
      "clintox_ct_tox": "moderate",
      "hepatotoxicity_ml": "low",
      "cardiotoxicity_ml": "low"
    },
    "pri_n_endpoints": 16,
    "pri_weights": {
      "ad_score": 0.3,
      "ensemble_uncertainty": 0.25,
      "conformal_width": 0.2,
      "model_performance": 0.25
    },
    "cds_score": 24.9,
    "cds_category": "poor",
    "cds_traffic_light": "red",
    "cds_drug_likeness": 37.0,
    "cds_metabolic_stability": 5.0,
    "cds_safety_profile": 40.0,
    "cds_permeability": 45.0,
    "cds_physicochemical": 0,
    "cds_critical_liabilities": "Severe metabolic instability; Unfavorable physicochemical properties; Cardiac liability (hERG)",
    "cds_optimization": "Improve Physicochemical (score: 0/100);   - Address: Very high MW (658 Da); Improve Metabolic stability (score: 5/100);   - Address: High LogP (5.5) \u2014 metabolic instability risk;   - Address: High MW (658) \u2014 increased metabolic sites",
    "cds_regulatory_risk": "low",
    "cds_regulatory_flags": "Regulatory: 2 Ro5 violations \u2014 bioavailability justification needed",
    "cds_benchmark_percentile": 25.0,
    "cds_benchmark_comparison": "MW: outside typical range (657.7); Logp: outside typical range (5.5); TPSA: acceptable (122.8); Rotatable Bonds: higher than typical (11, median=5)",
    "bcs_class": "IV",
    "bcs_description": "Low solubility, low permeability - significant formulation challenges",
    "bcs_solubility_category": "low",
    "bcs_permeability_category": "low",
    "bcs_biowaiver_eligible": false,
    "bcs_development_risk": "high",
    "bcs_absorption_score": 24.0,
    "bcs_logS": -6.98,
    "bcs_solubility_mg_ml": 0.0001,
    "bcs_permeability_score": 0.567,
    "bcs_permeability_sources": "Descriptors",
    "bcs_logS_pH1.2": 0.32,
    "bcs_logS_pH4.5": -2.98,
    "bcs_logS_pH6.8": -5.27,
    "bcs_logS_pH7.4": -5.84,
    "bcs_estimated_pka": 8.5,
    "bcs_ionization_type": "base",
    "bcs_formulation_strategies": "Amorphous nanoparticle formulations; Lipid nanoparticles (SLN, NLC); Polymeric micelles or nanocapsules; Prodrug strategy (improve both S and P)",
    "bcs_formulation_considerations": "Both dissolution AND permeation are rate-limiting; Oral bioavailability typically <30%; Advanced formulation technology required",
    "bcs_recommended_excipients": "Nanocarriers: PLGA nanoparticles, Lipid nanocapsules; Complexation: HP-\u03b2-cyclodextrin, SBE-\u03b2-cyclodextrin (Captisol); Advanced Lipids: Self-emulsifying systems, Microemulsions",
    "metabolism_n_metabolites": 12,
    "metabolism_primary_cyps": "CYP3A4, CYP1A2, CYP2C9, CYP2D6, Amidases",
    "metabolism_reactive_risk": "low",
    "metabolism_liability_score": 54.0,
    "metabolism_soft_spots": "Aromatic hydroxylation (CYP-mediated); N-dealkylation (general alkyl removal); N-oxidation of tertiary amine; Amide hydrolysis",
    "metabolism_reaction_types": "oxidation: 9; hydrolysis: 2; dealkylation: 1",
    "metabolism_dili_risk": "low",
    "metabolite_1_smiles": "CC(C)c1c(F)ccc(NC(=O)COc2ccc(-c3cnc4cc(F)c(OCC5CCN(CC6CC(=O)NC(=O)C6)C5)cc4n3)cc2)c1O",
    "metabolite_1_reaction": "Aromatic hydroxylation (CYP-mediated)",
    "metabolite_1_cyps": "CYP1A2, CYP2C9, CYP2D6",
    "metabolite_1_priority": 1,
    "metabolite_2_smiles": "CC(C)c1cc(NC(=O)COc2ccc(-c3cnc4cc(F)c(OCC5CCN(CC6CC(=O)NC(=O)C6)C5)cc4n3)cc2O)ccc1F",
    "metabolite_2_reaction": "Aromatic hydroxylation (CYP-mediated)",
    "metabolite_2_cyps": "CYP1A2, CYP2C9, CYP2D6",
    "metabolite_2_priority": 1,
    "metabolite_3_smiles": "CC(C)c1cc(NC(=O)COc2ccc(-c3cnc4cc(F)c(OCC5CCN(CC6CC(=O)NC(=O)C6)C5)cc4n3)c(O)c2)ccc1F",
    "metabolite_3_reaction": "Aromatic hydroxylation (CYP-mediated)",
    "metabolite_3_cyps": "CYP1A2, CYP2C9, CYP2D6",
    "metabolite_3_priority": 1,
    "metabolite_4_smiles": "CC(C)c1cc(NC(=O)COc2ccc(-c3nc4cc(OCC5CCN(CC6CC(=O)NC(=O)C6)C5)c(F)cc4nc3O)cc2)ccc1F",
    "metabolite_4_reaction": "Aromatic hydroxylation (CYP-mediated)",
    "metabolite_4_cyps": "CYP1A2, CYP2C9, CYP2D6",
    "metabolite_4_priority": 1,
    "metabolite_5_smiles": "CC(C)c1cc(NC(=O)COc2ccc(-c3cnc4c(O)c(F)c(OCC5CCN(CC6CC(=O)NC(=O)C6)C5)cc4n3)cc2)ccc1F",
    "metabolite_5_reaction": "Aromatic hydroxylation (CYP-mediated)",
    "metabolite_5_cyps": "CYP1A2, CYP2C9, CYP2D6",
    "metabolite_5_priority": 1,
    "cyp3a4_inhibitor": 0.5499999999999999,
    "cyp2d6_inhibitor": 0.35,
    "cyp2c9_inhibitor": 0.35,
    "cyp2c19_inhibitor": 0.35,
    "cyp1a2_inhibitor": 0.30000000000000004,
    "ddi_risk_score": 56.5,
    "ddi_risk_category": "moderate",
    "ddi_n_cyp_interactions": 5,
    "ddi_max_inhibition": "moderate",
    "ddi_moderate_inhibitions": "CYP3A4",
    "ddi_primary_pathway": "CYP3A4 (moderate inhibitor, P=0.55)",
    "ddi_pgp_risk": "minimal",
    "ddi_clinical_warnings": "Moderate CYP3A4 inhibitor - 2-5 fold AUC increase in CYP3A4 substrates",
    "ddi_monitoring": "Caution with narrow TI CYP3A4 substrates: Tacrolimus, Cyclosporine",
    "ddi_induction_risk": "CYP3A4 induction risk (Rifamycin-like scaffold (potent PXR activator)); CYP2C9 induction risk (Rifamycin-like scaffold (potent PXR activator)); CYP2C19 induction risk (Rifamycin-like scaffold (potent PXR activator))",
    "ddi_perpetrator_role": "weak_perpetrator",
    "ddi_victim_role": "none",
    "ddi_known_interactions": "Sildenafil (CYP3A4 moderate inhibition): Hypotension \u2014 reduce dose to 25mg; Apixaban (CYP3A4 moderate inhibition): Bleeding risk \u2014 dose adjustment",
    "ddi_cyp1_enzyme": "CYP3A4",
    "ddi_cyp1_prob": 0.55,
    "ddi_cyp1_strength": "moderate",
    "ddi_cyp1_at_risk": "Midazolam, Triazolam, Simvastatin, Lovastatin",
    "ddi_cyp2_enzyme": "CYP2C19",
    "ddi_cyp2_prob": 0.35,
    "ddi_cyp2_strength": "weak",
    "ddi_cyp2_at_risk": "Omeprazole, Clopidogrel, Diazepam, Citalopram",
    "ddi_cyp3_enzyme": "CYP2C9",
    "ddi_cyp3_prob": 0.35,
    "ddi_cyp3_strength": "weak",
    "ddi_cyp3_at_risk": "Warfarin (S), Phenytoin, Celecoxib, Losartan",
    "comparative_n_similar": 1,
    "comparative_drug_space_score": 100.0,
    "comparative_within_drug_space": true,
    "comparative_most_similar": "Imatinib",
    "comparative_similarity": 0.194,
    "comparative_drug_1_name": "Imatinib",
    "comparative_drug_1_class": "Kinase inhibitor",
    "comparative_drug_1_similarity": 0.194,
    "comparative_drug_1_bcs": "II",
    "comparative_strengths": "TPSA in optimal range (122.8)",
    "comparative_weaknesses": "LogP too high (5.5, optimal: -0.5-5.0); Molecular weight too high (657.7, optimal: 150-500); Weak Absorption profile (score: 21/100); Higher LogP than similar drugs (5.5 vs avg 3.5 in Imatinib); Higher MW than similar drugs (657.7 vs avg 493.6 in Imatinib)",
    "bro5_compound_class": "bro5_small",
    "bro5_is_bro5": true,
    "bro5_ro5_violations": 2,
    "bro5_drug_likeness": 100.0,
    "bro5_oral_bioavailability_risk": "low",
    "bro5_violation_details": "MW=658 (>500); LogP=5.47 (>5)",
    "bro5_fsp3": 0.361,
    "bro5_n_rotatable_bonds": 11,
    "bro5_chameleonicity": 0.626,
    "bro5_description": "Moderate bRo5 compound (MW=658, 2 Ro5 violations)",
    "aop_n_triggered": 2,
    "aop_risk_score": 18.4,
    "aop_risk_category": "low",
    "aop_organs_at_risk": "liver, kidney",
    "aop_highest_concern": "AOP:25: Drug-induced liver injury (DILI) (confidence=0.51)",
    "aop_1_id": "AOP:25",
    "aop_1_name": "Mitochondrial dysfunction leading to liver injury",
    "aop_1_outcome": "Drug-induced liver injury (DILI)",
    "aop_1_organ": "liver",
    "aop_1_confidence": 0.51,
    "aop_1_mie": "Inhibition of mitochondrial complex I/III",
    "aop_2_id": "AOP:NEPHRO_ROS",
    "aop_2_name": "Reactive oxygen species generation leading to glomerular injury",
    "aop_2_outcome": "Glomerulonephritis / Chronic kidney disease",
    "aop_2_organ": "kidney",
    "aop_2_confidence": 0.45,
    "aop_2_mie": "Mitochondrial electron transport chain disruption in podocytes"
  }
}